Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
L. Paermentier, A. Cano, B. Chabrol & A. Roy. (2023) Neuropsychological Disorders in Moderate Hyperphenylalaninemia: Literature Review. Developmental Neuropsychology 48:1, pages 31-45.
Read now
Read now
Leticia Ceberio, Álvaro Hermida, Eva Venegas, Francisco Arrieta, Montserrat Morales, Maria Forga & Montserrat Gonzalo. (2019) Phenylketonuria in the adult patient. Expert Opinion on Orphan Drugs 7:6, pages 265-276.
Read now
Read now
Júlio César Rocha & Anita MacDonald. (2018) Treatment options and dietary supplements for patients with phenylketonuria. Expert Opinion on Orphan Drugs 6:11, pages 667-681.
Read now
Read now
Articles from other publishers (82)
Kendra J. Bjoraker, Caroline Eggerding, Elisheva Ellenberg, Suzanne Hollander, Brittany M. Holmes, Kristin Lindstrom, Markey McNutt, Suzanne Miller, Hope Northrup, Meaghan Rogers, Sarah Rose, Mia Scott, Soo Shim, Bridget Wardley, Leah Wessenberg & Deborah A. Bilder. (2024) Best practice recommendations for the management of anxiety during the pegvaliase journey. Molecular Genetics and Metabolism 141:1, pages 107737.
Crossref
Crossref
Alex Pinto, Anne Daly, Júlio César Rocha, Catherine Ashmore, Sharon Evans, Fatma Ilgaz, Mary Hickson & Anita MacDonald. (2023) Natural Protein Intake in Children with Phenylketonuria: Prescription vs. Actual Intakes. Nutrients 15:23, pages 4903.
Crossref
Crossref
Júlio César Rocha, Kirsten K. Ahring, Heather Bausell, Deborah A. Bilder, Cary O. Harding, Anita Inwood, Nicola Longo, Ania C. Muntau, André L. Santos Pessoa, Fran Rohr, Serap Sivri & Álvaro Hermida. (2023) Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria. Nutrients 15:18, pages 3940.
Crossref
Crossref
Michael Martinez, Cary O. Harding, Gerald Schwank & Beat Thöny. (2023) State‐of‐the‐art 2023 on gene therapy for phenylketonuria. Journal of Inherited Metabolic Disease.
Crossref
Crossref
Meriah S. Schoen, Kelly M. Boland, Shawn E. Christ, Xiangqin Cui, Usha Ramakrishnan, Thomas R. Ziegler, Jessica A. Alvarez & Rani H. Singh. (2023) Total choline intake and working memory performance in adults with phenylketonuria. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Ida Vanessa Doederlein Schwartz, Andrea Amaro Quesada, Erlane Marques Ribeiro, Ana Maria Martins, Daniel Reda Fenga Vilela & André Pessoa. (2023) Neuropsychological and quality of life outcomes in PKU patients: expert recommendations of assessment tools in Brazil. Arquivos de Neuro-Psiquiatria 81:07, pages 685-695.
Crossref
Crossref
Shawn E. Christ, Hayley E. Clocksin, Maia Zalik, Benjamin D. Goodlett, Stephanie J. Sacharow & Emily E. Abbene. (2023) Neuropsychological assessment of adults with phenylketonuria using the NIH toolbox. Molecular Genetics and Metabolism 139:1, pages 107579.
Crossref
Crossref
P. M. Luna, J. F. López-Paz, M. García, I. Amayra, O. Martínez, M. Pérez, A. A. Rodríguez, P. Pérez-Núñez, I. Ceberio, N. Mansilla & C. Soria. (2023) Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients. Behavioural Neurology 2023, pages 1-9.
Crossref
Crossref
Christian Costa-Lathan, Nestor Vazquez-Agra, Ana-Teresa Marques-Afonso, Anton Cruces-Sande, Miguel-Angel Martinez-Olmos, David Araujo-Vilar & Alvaro Hermida-Ameijeiras. (2023) The role of phenylalanine levels in the neuropsychological and neuroanatomical status of adult patients with phenylketonuria: The impact of fluctuations. Journal of Investigative Medicine 71:2, pages 149-158.
Crossref
Crossref
Lucie Thomas, Andrew Olson & Cristina Romani. (2023) The impact of metabolic control on cognition, neurophysiology, and well-being in PKU: A systematic review and meta-analysis of the within-participant literature. Molecular Genetics and Metabolism 138:1, pages 106969.
Crossref
Crossref
D.L. Marsden, B. Reineking & F.J. Rohr. 2023. Encyclopedia of Human Nutrition. Encyclopedia of Human Nutrition
424
431
.
Filippo Manti, Stefania Caviglia, Chiara Cazzorla, Annamaria Dicintio, Andrea Pilotto & Alessandro P. Burlina. (2022) Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
A. L. S. Pessoa, A. M. Martins, E. M. Ribeiro, N. Specola, A. Chiesa, D. Vilela, E. Jurecki, D. Mesojedovas & I. V. D. Schwartz. (2022) Burden of phenylketonuria in Latin American patients: a systematic review and meta-analysis of observational studies. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Frances Rohr, Ann Wessel, Cary O. Harding, Susan E. Waisbren, Krista Viau & Amy Kritzer. (2022) Reinstitution of pegvaliase therapy during lactation. Molecular Genetics and Metabolism Reports 33, pages 100938.
Crossref
Crossref
Cristina Romani, Andrew Olson, Lynne Aitkenhead, Lucy Baker, Dhanesha Patel, Francjan Van Spronsen, Anita MacDonald, Annemiek van Wegberg & Stephan Huijbregts. (2022) Meta-analyses of cognitive functions in early-treated adults with phenylketonuria. Neuroscience & Biobehavioral Reviews 143, pages 104925.
Crossref
Crossref
Raphaela Muri, Stephanie Maissen‐Abgottspon, Christian Rummel, Michael Rebsamen, Roland Wiest, Michel Hochuli, Bernadette M. Jansma, Roman Trepp & Regula Everts. (2022) Cortical thickness and its relationship to cognitive performance and metabolic control in adults with phenylketonuria. Journal of Inherited Metabolic Disease 45:6, pages 1082-1093.
Crossref
Crossref
Hayley E. Clocksin, Emily E. Abbene & Shawn Christ. (2022) A comprehensive assessment of neurocognitive and psychological functioning in adults with early-treated phenylketonuria. Journal of the International Neuropsychological Society, pages 1-10.
Crossref
Crossref
Barbara K. Burton, Álvaro Hermida, Amaya Bélanger-Quintana, Heather Bell, Kendra J. Bjoraker, Shawn E. Christ, Mitzie L. Grant, Cary O. Harding, Stephan C.J. Huijbregts, Nicola Longo, Markey C. McNuttIIII, Mina D. Nguyen-Driver, André L. Santos Pessoa, Júlio César Rocha, Stephanie Sacharow, Amarilis Sanchez-Valle, H. Serap Sivri, Jerry Vockley, Mark Walterfang, Sarah Whittle & Ania C. Muntau. (2022) Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach. Molecular Genetics and Metabolism 137:1-2, pages 114-126.
Crossref
Crossref
Neha Sarodaya, Apoorvi Tyagi, Hyun-Jin Kim, Ju-Seop Kang, Vijai Singh, Seok-Ho Hong, Woo Jin Kim, Kye-Seong Kim & Suresh Ramakrishna. (2022) Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants. Scientific Reports 12:1.
Crossref
Crossref
Debra S. Regier, Agata Bąk, Heather Bausell, Emer O'Reilly & Lex M. Cowsert. (2022) Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates. Molecular Genetics and Metabolism Reports 31, pages 100855.
Crossref
Crossref
Meriah S Schoen & Rani H Singh. (2022) Plasma metabolomic profile changes in females with phenylketonuria following a camp intervention. The American Journal of Clinical Nutrition 115:3, pages 811-821.
Crossref
Crossref
Deborah A. Bilder, Georgianne L. Arnold, David Dimmock, Mitzie L. Grant, Darren Janzen, Nicola Longo, Mina Nguyen‐Driver, Elaina Jurecki, Markus Merilainen, Gianni Amato & Susan Waisbren. (2021) Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria. American Journal of Medical Genetics Part A 188:3, pages 768-778.
Crossref
Crossref
Elisabetta Anna Tendi, Maria Guarnaccia, Giovanna Morello & Sebastiano Cavallaro. (2022) The Utility of Genomic Testing for Hyperphenylalaninemia. Journal of Clinical Medicine 11:4, pages 1061.
Crossref
Crossref
Rebecca M. Pollak, Ryan H. Purcell, Timothy P. Rutkowski, Tamika Malone, Kimberly J. Pachura, Gary J. Bassell, Michael P. Epstein, Paul A. Dawson, Matthew R. Smith, Dean P. Jones, Michael E. Zwick, Stephen T. Warren, Tamara Caspary, David Weinshenker & Jennifer G. Mulle. (2022) Metabolic effects of the schizophrenia-associated 3q29 deletion. Translational Psychiatry 12:1.
Crossref
Crossref
Tanyel ZubariogluDuhan HopurcuogluEsma UygurSaffa AhmadzadaEce Oge-EnverEsra IsatMehmet Serif CanseverErtugrul KiykimCigdem Aktuglu-Zeybek. (2022) The Impact of Telemedicine for Monitoring and Treatment of Phenylketonuria Patients on Metabolic Outcome During Coronavirus Disease-19 Outbreak. Telemedicine and e-Health 28:2, pages 258-265.
Crossref
Crossref
Jennifer Quinn, Alexandros Georgiadis, Hannah B. Lewis & Elaina Jurecki. (2021) Measuring Burden of Illness in Phenylketonuria (PKU): Development of the PKU Symptom Severity and Impacts Scale as a Robust Patient-Reported Outcome. Advances in Therapy 39:2, pages 971-991.
Crossref
Crossref
Stephanie Abgottspon, Raphaela Muri, Shawn E. Christ, Michel Hochuli, Piotr Radojewski, Roman Trepp & Regula Everts. (2022) Neural correlates of working memory and its association with metabolic parameters in early-treated adults with phenylketonuria. NeuroImage: Clinical 34, pages 102974.
Crossref
Crossref
Domingo González-Lamuño, Paula Sánchez-Pintos, Fernando Andrade, María L. Couce & Luís Aldámiz-Echevarría. (2021) Treatment adherence in tyrosinemia type 1 patients. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Nicholas M. Burgess, Wendy Kelso, Charles B. Malpas, Toby Winton-Brown, Timothy Fazio, Julie Panetta, Gerard De Jong, Joanna Neath, Sonny Atherton, Dennis Velakoulis & Mark Walterfang. (2021) The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Barbara K. Burton, Anne Skalicky, Christoph Baerwald, Deborah A. Bilder, Cary O. Harding, Aaron B. Ilan, Elaina Jurecki, Nicola Longo, David T. Madden, H. Serap Sivri, Gisela Wilcox, Janet Thomas & Kathleen Delaney. (2021) A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials. Molecular Genetics and Metabolism Reports 29, pages 100810.
Crossref
Crossref
Aileen Kenneson & Rani H. Singh. (2021) Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry. Molecular Genetics and Metabolism 134:3, pages 243-249.
Crossref
Crossref
Madhukar Aryal, Kelly Lau, Ryan Boyer, Huiyu Zhou, Johanna Abend, Karen Gu, Joy Olbertz, Soumi Gupta, Stephen Zoog & Kevin Larimore. (2021) Achieving efficacy in subjects with sustained pegvaliase-neutralizing antibody responses. Molecular Genetics and Metabolism 134:3, pages 235-242.
Crossref
Crossref
Kristin J. Adolfsen, Isolde Callihan, Catherine E. Monahan, Per Greisen, James Spoonamore, Munira Momin, Lauren E. Fitch, Mary Joan Castillo, Lindong Weng, Lauren Renaud, Carl J. Weile, Jay H. Konieczka, Teodelinda Mirabella, Andres Abin-Fuentes, Adam G. Lawrence & Vincent M. Isabella. (2021) Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering. Nature Communications 12:1.
Crossref
Crossref
Yulan Qi, Gina Patel, Joshua Henshaw, Soumi Gupta, Joy Olbertz, Kevin Larimore, Cary O. Harding, Markus Merilainen, Roberto Zori, Nicola Longo, Barbara K. Burton, Mingjin Li, Zhonghua Gu, Stephen J. Zoog, Haoling H. Weng & Becky Schweighardt. (2021) Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria. Clinical and Translational Science 14:5, pages 1894-1905.
Crossref
Crossref
Marek Walkowiak, Łukasz Kałużny, Renata Mozrzymas, Małgorzata Jamka, Bożena Mikołuć, Joanna Jagłowska, Ewa Starostecka, Roza Nurgaliyeva, Jarosław Walkowiak & Aleksandra Lisowska. (2021) Helicobacter pylori Infection in Children with Phenylketonuria Does Not Depend on Metabolic Control and Is Not More Frequent Than in Healthy Subjects—A Cross-Sectional Study. Children 8:8, pages 713.
Crossref
Crossref
Rodolfo Ramos-Álvarez, Maili Kapp, María Mercedes Rodríguez-Ruiz, Rocío Fausor, María Amor Bueno-Delgado, Kirsten Ahring & Susan E. Waisbren. (2021) Adaptation and Validation of a Questionnaire to Evaluate Knowledge of the Low Phe Diet in PKU. Nutrients 13:8, pages 2719.
Crossref
Crossref
Tina Mainka, Jan-Frederik Fischer, Julius Huebl, Alexandra Jung, Dinah Lier, Alexandra Mosejova, Matej Skorvanek, Tom J. de Koning, Andrea A. Kühn, Peter Freisinger, Athanasia Ziagaki & Christos Ganos. (2021) The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria. Parkinsonism & Related Disorders 89, pages 167-175.
Crossref
Crossref
Marja K. Puurunen, Jerry Vockley, Shawn L. Searle, Stephanie J. Sacharow, John A. PhillipsIIIIII, William S. Denney, Benjamin D. Goodlett, David A. Wagner, Larry Blankstein, Mary J. Castillo, Mark R. Charbonneau, Vincent M. Isabella, Vasu V. Sethuraman, Richard J. Riese, Caroline B. Kurtz & Aoife M. Brennan. (2021) Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study. Nature Metabolism 3:8, pages 1125-1132.
Crossref
Crossref
Zhilei Zhang, Dingyuan Ma, Xin Wang, Yanyun Wang, Yahong Li, Peiyin Yang, Yun Sun, Tao Jiang & Zhengfeng Xu. (2021) A joint method for the screening of pharmacological chaperones for phenylalanine hydroxylase. Organic & Biomolecular Chemistry 19:26, pages 5827-5835.
Crossref
Crossref
Melissa Lah & Molly McPheron. (2021) Palynziq clinic: One year and 43 patients later. Molecular Genetics and Metabolism 133:3, pages 250-256.
Crossref
Crossref
Francjan J. van Spronsen, Nenad Blau, Cary Harding, Alberto Burlina, Nicola Longo & Annet M. Bosch. (2021) Phenylketonuria. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Vanessa Trindade Bortoluzzi, Carlos Severo Dutra Filho & Clovis Milton Duval Wannmacher. (2021) Oxidative stress in phenylketonuria—evidence from human studies and animal models, and possible implications for redox signaling. Metabolic Brain Disease 36:4, pages 523-543.
Crossref
Crossref
Maria Peres, Manuela F. Almeida, Élia J. Pinto, Carla Carmona, Sara Rocha, Arlindo Guimas, Rosa Ribeiro, Esmeralda Martins, Anabela Bandeira, Anita MacDonald & Júlio C. Rocha. (2021) Implementing a Transition Program from Paediatric to Adult Services in Phenylketonuria: Results after Two Years of Follow-Up with an Adult Team. Nutrients 13:3, pages 799.
Crossref
Crossref
Mustafa Çelebier, Tuba Reçber, Emirhan Nemutlu & Sedef Kır. (2021) Ultrafiltration-based Extraction and LC-MS/MS Quantification of Phenylalanine in Human Blood Sample for Metabolite Target Analysis. Current Pharmaceutical Analysis 17:1, pages 81-86.
Crossref
Crossref
Tracy B. Lowe, Jane DeLuca & Georgianne Arnold. (2020) Neurocognitive, neuropsychiatric, and neurological outcomes associated with phenylalanine hydroxylase deficiency: Assessment considerations for nurse practitioners. Journal for Specialists in Pediatric Nursing 26:1.
Crossref
Crossref
Lina Palaiodimou, Christina Zompola, Stefanos Lachanis, Varvara Mylona, Aikaterini Theodorou, Georgia Papagiannopoulou, Vasiliki Kotsali-Peteinelli, Aikaterini Foska, Arezina Kasti, Anastasia Skouma & Georgios Tsivgoulis. (2021) True Restriction in Diffusion-Weighted Imaging in a Mistreated Patient With Phenylketonuria. The Neurologist 26:1, pages 20-21.
Crossref
Crossref
Klaus Sarimski & Frank Häßler. 2020. Psychiatrie und Psychotherapie des Kindes- und Jugendalters. Psychiatrie und Psychotherapie des Kindes- und Jugendalters
1
12
.
Roman Trepp, Raphaela Muri, Stephanie Abgottspon, Lenka Bosanska, Michel Hochuli, Johannes Slotboom, Christian Rummel, Roland Kreis & Regula Everts. (2020) Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial. Trials 21:1.
Crossref
Crossref
Benedikt Sundermann, Stefan Garde, Mahboobeh Dehghan Nayyeri, Josef Weglage, Johanna Rau, Bettina Pfleiderer & Reinhold Feldmann. (2020) Approaching altered inhibitory control in phenylketonuria: A functional MRI study with a Go‐NoGo task in young female adults. European Journal of Neuroscience 52:8, pages 3951-3962.
Crossref
Crossref
Barbara K. Burton, Nicola Longo, Jerry Vockley, Dorothy K. Grange, Cary O. Harding, Celeste Decker, Mingjin Li, Kelly Lau, Orli Rosen, Kevin Larimore & Janet Thomas. (2020) Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up. Molecular Genetics and Metabolism 130:4, pages 239-246.
Crossref
Crossref
Fernanda Gabriel Santos da Silva, Filippo Pinto e Vairo, Carolina Fischinger Moura de Souza & Ida Vanessa Doederlein Schwartz. (2018) Attention-deficit hyperactivity disorder in Brazilian patients with phenylketonuria. Acta Neurologica Belgica 120:4, pages 893-899.
Crossref
Crossref
Jennifer Beazer, Jane Breck, Caroline Eggerding, Patricia Gordon, Stephanie Hacker & Amie Thompson. (2020) Strategies to engage lost to follow-up patients with phenylketonuria in the United States: Best practice recommendations. Molecular Genetics and Metabolism Reports 23, pages 100571.
Crossref
Crossref
Luigia Rossi, Francesca Pierigè, Mattia Paolo Aliano & Mauro Magnani. (2020) Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies. BioDrugs 34:3, pages 265-272.
Crossref
Crossref
Javad Shahpouri, Saeideh Karami, Davood Mohammadi, Mohsen Mollamohammadi & Abolfazl Mohammadbeigi. (2020) Efect of a controlled diet program on behavioral-emotional disorders in patients with phenylketonuria. Koomesh journal 22:2, pages 317-324.
Crossref
Crossref
Jessica S. Suddaby, Dorsa Sohaei, Heather Bell, Sandra Tavares, Grace Jieun Lee, Marta Szybowska & Joyce So. (2020) Adult patient perspectives on phenylketonuria care: Highlighting the need for dedicated adult management and services. European Journal of Medical Genetics 63:4, pages 103818.
Crossref
Crossref
Vincenzo Leuzzi, Flavia Chiarotti, Francesca Nardecchia, Danique van Vliet & Francjan J van Spronsen. (2020) Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines. Journal of Medical Genetics 57:3, pages 145-150.
Crossref
Crossref
Johannes Krämer. (2020) Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2 year prospective study. Molecular Genetics and Metabolism Reports 22, pages 100573.
Crossref
Crossref
Johannes Krämer. (2020) Case-control study about the acceptance of Pegvaliase in Phenylketonuria. Molecular Genetics and Metabolism Reports 22, pages 100557.
Crossref
Crossref
Fran Rohr, Amy Kritzer, Cary O. Harding, Krista Viau & Harvey L. Levy. (2020) Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report. Molecular Genetics and Metabolism Reports 22, pages 100555.
Crossref
Crossref
Emma R.L.C. Vardy, Anita MacDonald, Suzanne Ford & Denise L. Hofman. (2020) Phenylketonuria, co‐morbidity, and ageing: A review. Journal of Inherited Metabolic Disease 43:2, pages 167-178.
Crossref
Crossref
Helene Barone, Yngve T. Bliksrud, Irene B. Elgen, Peter D. Szigetvari, Rune Kleppe, Sadaf Ghorbani, Eirik V. Hansen & Jan Haavik. (2019) Tyrosinemia Type 1 and symptoms of ADHD: Biochemical mechanisms and implications for treatment and prognosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183:2, pages 95-105.
Crossref
Crossref
Annemarie Klimek, Christoph Baerwald, Martin Schwarz, Frank Rutsch, Klaus G. Parhofer, Ursula Plöckinger, Margret Heddrich-Ellerbrok, Stephan vom Dahl, Klaus Schöne, Markus Ott, Frauke Lang & Julia B. Hennermann. (2020) Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study. Annals of Nutrition and Metabolism 76:4, pages 251-258.
Crossref
Crossref
Cary O. Harding. (2019) Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU). Molecular Frontiers Journal 03:02, pages 110-121.
Crossref
Crossref
Sumitra Sri Bhashyam, Kevin Marsh, Adrian Quartel, Haoling H. Weng, Ari Gershman, Nicola Longo, Janet Thomas & Roberto Zori. (2019) A benefit-risk analysis of pegvaliase for the treatment of phenylketonuria: A study of patients' preferences. Molecular Genetics and Metabolism Reports 21, pages 100507.
Crossref
Crossref
Geoffrey Y. Berguig, Nathan T. Martin, Athena Y. Creer, Lin Xie, Lening Zhang, Ryan Murphy, Glenn Pacheco, Sherry Bullens, Joy Olbertz & Haoling H. Weng. (2019) Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain. Molecular Genetics and Metabolism 128:4, pages 422-430.
Crossref
Crossref
Vanessa Trindade Bortoluzzi, Letícia Brust, Thales Preissler, Itiane Diehl de Franceschi & Clovis Milton Duval Wannmacher. (2019) Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria. Metabolic Brain Disease 34:6, pages 1649-1660.
Crossref
Crossref
Kimberly J. Erlich. (2019) Case Report: Neuropsychiatric Symptoms in PKU Disease. Journal of Pediatric Health Care 33:6, pages 718-721.
Crossref
Crossref
Hiu Man Grisch-Chan, Gerald Schwank, Cary O. HardingBeat Thöny. (2019) State-of-the-Art 2019 on Gene Therapy for Phenylketonuria. Human Gene Therapy 30:10, pages 1274-1283.
Crossref
Crossref
Killian Ashe, Wendy Kelso, Sarah Farrand, Julie Panetta, Tim Fazio, Gerard De Jong & Mark Walterfang. (2019) Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments. Frontiers in Psychiatry 10.
Crossref
Crossref
Roberto Zori, Kirsten Ahring, Barbara Burton, Gregory M. Pastores, Frank Rutsch, Ashok Jha, Elaina Jurecki, Richard Rowell & Cary Harding. (2019) Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria. Molecular Genetics and Metabolism 128:1-2, pages 92-101.
Crossref
Crossref
Oliver Hausmann, Mohamed Daha, Nicola Longo, Edward Knol, Ingo Müller, Hope Northrup & Knut Brockow. (2019) Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy. Molecular Genetics and Metabolism 128:1-2, pages 84-91.
Crossref
Crossref
Nicola Longo, David Dimmock, Harvey Levy, Krista Viau, Heather Bausell, Deborah A. Bilder, Barbara Burton, Christel Gross, Hope Northrup, Fran Rohr, Stephanie Sacharow, Amarilis Sanchez-Valle, Mary Stuy, Janet Thomas, Jerry Vockley, Roberto Zori & Cary O. Harding. (2019) Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genetics in Medicine 21:8, pages 1851-1867.
Crossref
Crossref
Florian Ferreri, Alexis Bourla, Jean Capron, Bluenn Quillerou, Julien Rossignol, Alaina Borden, Jérome Guechot, Antonin Lamaziere, Philippe Nuss, Arsène Mekinian & Stéphane Mouchabac. (2019) Intrications organo-psychiatriques : le concept de troubles psychiatriques complexes, quels examens complémentaires ?. La Presse Médicale 48:6, pages 609-624.
Crossref
Crossref
Denise Leonne Hofman, Claire Louise Champ, Clare Louise Lawton, Mick Henderson & Louise Dye. (2018) A systematic review of cognitive functioning in early treated adults with phenylketonuria. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Suzanne Ford, Mike O'Driscoll & Anita MacDonald. (2018) Living with Phenylketonuria: Lessons from the PKU community. Molecular Genetics and Metabolism Reports 17, pages 57-63.
Crossref
Crossref
Barbara K. Burton, Kyle Bradford Jones, Stephen Cederbaum, Fran Rohr, Susan Waisbren, Debra E. Irwin, Gilwan Kim, Joshua Lilienstein, Ignacio Alvarez, Elaina Jurecki & Harvey Levy. (2018) Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria. Molecular Genetics and Metabolism 125:3, pages 228-234.
Crossref
Crossref
Roberto Zori, Janet A. Thomas, Natasha Shur, William B. Rizzo, Celeste Decker, Orli Rosen, Mingjin Li, Becky Schweighardt, Kevin Larimore & Nicola Longo. (2018) Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria. Molecular Genetics and Metabolism 125:3, pages 217-227.
Crossref
Crossref
Ismail Mucahit Alptekin, Nevra Koc, Mehmet Gunduz & Funda Pinar Cakiroglu. (2018) The impact of phenylketonuria on PKU patients’ quality of life: Using of the phenylketonuria-quality of life (PKU-QOL) questionnaires. Clinical Nutrition ESPEN 27, pages 79-85.
Crossref
Crossref
Janet Thomas, Harvey Levy, Stephen Amato, Jerry Vockley, Roberto Zori, David Dimmock, Cary O. Harding, Deborah A. Bilder, Haoling H. Weng, Joy Olbertz, Markus Merilainen, Joy Jiang, Kevin Larimore, Soumi Gupta, Zhonghua Gu & Hope Northrup. (2018) Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM). Molecular Genetics and Metabolism 124:1, pages 27-38.
Crossref
Crossref
Cary O. Harding, R. Stephen Amato, Mary Stuy, Nicola Longo, Barbara K. Burton, John Posner, Haoling H. Weng, Markus Merilainen, Zhonghua Gu, Joy Jiang & Jerry Vockley. (2018) Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial. Molecular Genetics and Metabolism 124:1, pages 20-26.
Crossref
Crossref
Bozena Didycz & Miroslaw Bik-Multanowski. (2018) Blood phenylalanine instability strongly correlates with anxiety in phenylketonuria. Molecular Genetics and Metabolism Reports 14, pages 80-82.
Crossref
Crossref
Barbara K. Burton, Álvaro Hermida, Amaya Bélanger-Quintana, Heather Bell, Kendra J. Bjoraker, Shawn E. Christ, Mitzie L. Grant, Cary O. Harding, Stephan C.J. Huijbregts, Nicola Longo, Markey C. McNutt, Mina D. Nguyen-Driver, André L. Santos Pessoa, Júlio César Rocha, Stephanie Sacharow, Amarilis Sanchez-Valle, H. Serap Sivri, Jerry Vockley, Mark Walterfang, Sarah Whittle & Ania C. Muntau. (2022) Management of Early Treated Adolescents and Young Adults with Phenylketonuria: Development of International Consensus Recommendations Using a Modified Delphi Approach. SSRN Electronic Journal.
Crossref
Crossref